In vitro immunologic effects with potential benefit were seen with high daily supplementation in a pilot trial.
Vitamin D has a multitude of biological effects, including an impact on the immune system. Studies have shown an increased risk to develop multiple sclerosis (MS) in those who have low vitamin D levels and increased numbers of brain lesions on imaging for those with low serum levels after diagnosis (NEJM JW Neurol Dec 2015 and JAMA Neurol 2015; 72:1458).
In this single-center study, researchers randomized 40 patients with MS to 800 IU (low dose) or 10,400 IU (high dose) of cholecalciferol daily for 6 months. Patients with severe vitamin D deficiency were excluded (<20 ng/mL). Serum vitamin D increased from baseline by 34.9 ng/mL in the high-dose arm and by 6.9 ng/mL in the low-dose arm. One relapse occurred in each arm. The percentages of IL…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)